Lambert Kuk

Lambert Kuk is a global investment executive and venture capitalist currently serving as Chief Investment Officer at KB Investment, the venture capital platform of KB Financial Group. Based between Seoul and Boston, he leads the firm’s global investment activities across biotechnology, healthcare, AI, and deep technology. With over 15 years of experience spanning venture capital, healthcare strategy, and global business development, Lambert has built extensive expertise across the U.S. and Asian innovation ecosystems. Prior to KB Investment, he worked at Samsung Medical Center and IQVIA, where he was involved in healthcare strategy, clinical and commercial evaluation, and life sciences-related business development. At KB Investment, Lambert has played a key role in building the firm’s international investment platform and global network across venture capital firms, pharmaceutical companies, healthcare institutions, and strategic investors. His experience includes sourcing and managing investments, supporting portfolio companies through fundraising and business development, and participating in IPO and M&A processes across the U.S. and Asia. Over the course of his investment career, Lambert has led or managed investments in more than 52 portfolio companies globally. Selected investments and transactions include Aculys Pharma, Odyssey Therapeutics, BioProtect, Rznomics, LigaChem Biosciences, Orum Therapeutics, Bright Peak Therapeutics, and Cartography Biosciences.